title: Factors related to HIV-associated neurocognitive impairment differ with age.
abstract: Over 50% of HIV-infected (HIV+) persons are expected to be over age 50 by 2015. The pathogenic effects of HIV, particularly in cases of long-term infection, may intersect with those of age-related illnesses and prolonged exposure to combined antiretroviral therapy (cART). One potential outcome is an increased prevalence of neurocognitive impairment in older HIV+ individuals, as well as an altered presentation of HIV-associated neurocognitive disorders (HANDs). In this study, we employed stepwise regression to examine 24 features sometimes associated with HAND in 40 older (55-73 years of age) and 30 younger (32-50 years of age) HIV+, cART-treated participants without significant central nervous system confounds. The features most effective in generating a true assessment of the likelihood of HAND diagnosis differed between older and younger cohorts, with the younger cohort containing features associated with drug abuse that were correlated to HAND and the older cohort containing features that were associated with lipid disorders mildly associated with HAND. As the HIV-infected population grows and the demographics of the epidemic change, it is increasingly important to re-evaluate features associated with neurocognitive impairment. Here, we have identified features, routinely collected in primary care settings, that provide more accurate diagnostic value than a neurocognitive screening measure among younger and older HIV individuals.
authors.affiliation: Natural Selection, Inc., San Diego, CA, 92121, USA.
authors.forename: Gary B
authors.initials: GB
authors.lastname: Fogel
authors.forename: Susanna L
authors.initials: SL
authors.lastname: Lamers
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Levine
authors.forename: Miguel
authors.initials: M
authors.lastname: Valdes-Sueiras
authors.forename: Michael S
authors.initials: MS
authors.lastname: McGrath
authors.forename: Paul
authors.initials: P
authors.lastname: Shapshak
authors.forename: Elyse J
authors.initials: EJ
authors.lastname: Singer
mesh_terms: D015526:AIDS Dementia Complex / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000821:virology; D000328:Adult; D000367:Age Factors; D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003071:Cognition; D060825:Cognitive Dysfunction / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000821:virology; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000821:virology; D007858:Learning; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D009483:Neuropsychological Tests; D012720:Severity of Illness Index; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000821:virology; D019562:Viral Load